Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

      Asia
      Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19....

      AI to deliver next evolution of drug manufacturing and supply chain efficiency

      Drug Development
      In the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss...

      FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

      FDA Approvals
      Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for...

      FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial

      Clinical Trials
      FSD Pharma Inc. received approval from the U.S. FDA to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide,...

      Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients

      Clinical Trials
      Sun Pharmaceutical Industries Ltd. has announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial...

      POINT Biopharma to Launch First US Manufacturing Facility in Indiana

      Americas
      POINT Biopharma (POINT) announced plans today to establish its first U.S. manufacturing facility in Indianapolis. “Indiana has established itself as a global leader in...

      AstraZeneca Forges RNA-Modifying Protein Oncology Deal with Accent Therapeutics

      Drug Development
      Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.1 billion to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins (RMPs) for...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.